Latest Breaking News On - பிரீஸ்ம மீடியா - Page 13 : comparemela.com
Voici, Femme Actuelle… Bolloré veut racheter Prisma Média pour étendre son empire
seneweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seneweb.com Daily Mail and Mail on Sunday newspapers.
Vivendi In Talks To Acquire Prisma Media
PARIS (dpa-AFX) - Vivendi (VIV.L, VIVEF.PK) has entered into exclusive negotiations with Gruner + Jahr/Bertelsmann to acquire 100% of Prisma Media. Prisma Media is France s number one press publishing group, and is a subsidiary of Gruner + Jahr, part of the Bertelsmann group.
Vivendi said the acquisition would perfectly fit with its strategy as a leading media, content and communications group, complementing the scope of its existing activities. It would also offer interesting opportunities for cooperation within the Group and development of the high-quality Prisma Media publications, the company noted.
Copyright RTT News/dpa-AFX
French group Vivendi in talks to buy Prisma Media from Bertelsmann
leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
European Markets Close Mostly Higher
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European markets ended mostly higher on Monday thanks to positive news on the coronavirus vaccine front, and on hopes about a post-Brexit trade deal.
The European Union and the U.K. extended negotiations beyond the Sunday deadlline, with the British Prime Minister Boris Johnson and EU Commission President Ursula von der Leyen agreeing to go the extra mile in coming days to reach a deal.
On the vaccine front, the U.S.Centers for Disease Control and Prevention or CDC, gave the approval for Pfizer- BioNTech s COVID-19 vaccine, following the Emergency Use Authorization or EUA issued by the U.S. Food and Drug Administration. Pfizer commenced first shipments of the vaccine to distribution centers across the country.
European Stocks Higher On U.S. Vaccine Approval, Extended Brexit Talks
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks traded higher on Monday, despite mixed Asian cues, following news that the United States will start Covid-19 vaccinations today after the drug regulators approved the Pfizer- BioNTech s COVID-19 vaccine.
The U.S. Centers for Disease Control and Prevention or CDC, gave the approval for Pfizer- BioNTech s COVID-19 vaccine, following the Emergency Use Authorization or EUA issued by the U.S. Food and Drug Administration. Pfizer commenced first shipments of the vaccine to distribution centers across the country.
Investor sentiment also reflected hopes for a post-Brexit trade deal after the European union and the U.K. extended negotiations beyond the Sunday deadline. U.K Prime Minister Boris Johnson and EU Commission President Ursula von der Leyen agreed to go the extra mile in coming days to reach a deal.
vimarsana © 2020. All Rights Reserved.